Recently, Russia’s medical device regulator has rolled out a series of major regulatory updates. Roszdravnadzor, the Russian healthcare regulator, has suspended the registration validity of a large number of medical devices. Shortly after, VNIIIMT (All-Russian Research Institute for Medical Devices) officially released methodological guidance for compiling PKM reports. With enforcement actions paired with supporting guidance, Russia has formed a closed-loop regulatory framework for post-market clinical monitoring of high-risk medical devices. Manufacturers exporting medical devices to Russia must pay close attention.
https://pharmvestnik.ru/content/news/roszdravnadzor-massovo-priostanavlivaet-registraciu-medizdelii.html
https://vademec.ru/news/2026/10/30/vniiimt-podgotovil-metodicheskie-rekomendatsii-po-otchetam-o-klinicheskom-monitoringe-medizdeliy/
Given the widespread ambiguity over standards in the industry, VNIIIMT, the body responsible for technical assessment, has promptly released practical operational guidance.
Order No.541h entered into force on September 1, establishing the single online submission channel. Under Order No.541h: The manufacturer or its Russian authorized representative shall submit electronic post-market clinical monitoring reports annually for 3 consecutive years starting from the year after registration approval.
When carrying out registration variations, enterprises must assess in advance whether additional monitoring obligations are triggered, instead of focusing only on the variation approval itself.
Understand the 30-day grace period is not an extension allowance:The grace period is only a remedial window. Once registration suspension is triggered, product sales in Russia will be halted immediately, resulting in commercial losses.